Form D · Pharmaceuticals
SPAULDING CLINICAL RESEARCH LLC
West Bend, WI · CIK 0001422373
Offering snapshot reported Apr 25, 2012 · SEC filing
- Reported sold
- $870K Offering amount: $6M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $30K Reported outside-investor minimum
- First sale
- Mar 7, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 25, 2012 | Initial | $870,000 | No comparison | 3 | SEC filing |
| Sep 22, 2009 | Initial | $839,500 | No comparison | 9 | SEC filing |
| Dec 26, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-177235
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Apr 25, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Amanda Baltz | Executive, Promoter |
| Victoria Nonhof | Executive, Promoter |
| Randol R. Spaulding | Executive, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
525 S. Silverbrook Dr.
West Bend, WI, 53095
West Bend, WI, 53095